Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each patient's needs. Chris Bell, an acute care nurse practitioner who specializes ...

Symptoms of HF may include dizziness, shortness of breath ... increasing to around 40% after five years. • When categorized by left ventricular ejection fraction (LVEF), which is a measure of cardiac ...

Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is administered to reduce morbidity and mortality. Limited access to ...

The research found that for every 1 per cent increase in fatty muscle fraction, there was a 2 per ... physical activity or stressful situations. Symptoms usually pass in less than 10 minutes ...

But while many folks do improve at home thanks to a combination of medication, rest, hydration and time, others require additional medical intervention. While we know the hallmark symptoms of COVID ― ...